Skip to content

An observational study to develop pathological screening method for predicting genetic alteration in prostate cancer

An observational study to develop pathological screening method for predicting genetic alteration in prostate cancer - APPP study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044918
Enrollment
104
Registered
2021-08-01
Start date
2021-07-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancner

Interventions

None listed

Sponsors

Nagoya University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: mHSPC (Latitude high risk)

Exclusion criteria

Exclusion criteria: double cancer

Design outcomes

Primary

MeasureTime frame
Relationship between IDC-P and HRRm

Countries

Japan

Contacts

Public ContactMasashi Kato

Nagoya University Hospital Department of Urology

mk-kato@med.nagoya-u.ac.jp+81527442984

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026